FDA Approves LENVIMA® (lenvatinib) Plus KEYTRUDA® (pembrolizumab) Combination for First-Line Treatment of Adult Patients With
A Quantitative Postmortem MRI Design Sensitive to White Matter Hyperintensity Differences and Their Relationship With Underlying
Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles | Fierce Pharma
![When to Refer Patients to Palliative Care: Considerations for the Sustainable Practice of Patient-Centered Supportive Care in Oncology When to Refer Patients to Palliative Care: Considerations for the Sustainable Practice of Patient-Centered Supportive Care in Oncology](https://dailynews.ascopubs.org/do/10.1200/ADN.22.201092/full/mcalarnen_lindsey_570px.jpg)